Arcturus Therapeutics to Present Ornithine Transcarbamylase Deficiency Phase 2 Clinical Data and Provide Update on mRNA Liver Therapeutics Platform 10h
Arcturus Therapeutics Announces Second Quarter 2026 Financial Results and Pipeline Progress 06 August
